Scientists at Eli Lilly reported that its GLP-1 pill helped reduce the number of obstructive sleep apnea episodes people had, while another drug called retatrutide—an experimental weight-loss injection that the company is currently testing—helped ease pain caused by osteoarthritis in the knee. https://t.co/ezVMFwGuGR
In the phase 3 TRIUMPH-1 trial involving participants with obesity, retatrutide, a triple hormone receptor agonist, resulted in substantial weight reduction and a decrease in knee osteoarthritis pain and obstructive sleep apnea events. Full trial results and Research Summary: https://t.co/RyCnPv4grV